Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists.
C A
CA
Silagy
D000280:Administration, Inhalation; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009975:Orthomyxoviridae / Q000187:drug effects; D011714:Pyrans; D012299:Rimantadine / Q000627:therapeutic use; D012794:Sialic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D053243:Zanamivir
D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D012299:Rimantadine; D000547:Amantadine; D053243:Zanamivir